Drug
Tiotropium-olodaterol clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Name
- Stiolto Respimat
- 2
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Boehringer Ingelheim (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · RWTH Aachen University (1)
Studies
Open first, then newest update. How each study uses tiotropium-olodaterol is read from its arms, and is right about nine times in ten.
Testing it · 3
- Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPDWithdrawnPhase 4RWTH Aachen UniversityNCT02812862Written as Spiolto® Respimat® (Tiotropium / Olodaterol)
- Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]CompletedPhase 4Boehringer IngelheimNCT03265145Written as Stiolto Respimat
- The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary DiseaseCompletedPhase 4Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT02845752Written as Stiolto Respimat